[Synthesis of 6-benzyl-1-[(benzyloxy)methyl]-3-hydroxy-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione]. 2015

Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, Beijing 100191, China.

OBJECTIVE To find the best synthesis method of 6-benzyl-1-[(benzyloxy)methyl]-3-hydroxy-5-(hydroxymethyl) pyrimidine-2,4(1H,3H)-dione e for observing the change of its biological activity after N-3 hydroxylation. METHODS After trying some N-hydroxylation methods, the target compound was successfully synthesized via one-pot oxidizing process by sodium hydride (NaH) and 3-chloroperbenzoic acid(m-CPBA); the anti-HIV reverse transcriptase (RT) activity and integrase (IN) activity of the target compound was assayed via enzyme-linked immunesorbent assay (ELISA) and phosphorylation of DNA package method. RESULTS The target compound could be obtained through the improved m-CPBA oxidative method by only one step, and the yield of the reaction could reach 60%-70%. And the structure of this compound was identified by 1H NMR, 13C NMR and MS; The activity result showed it added the anti-HIV IN activity after N-3 hydroxylation as well as retained the anti-HIV RT activity. CONCLUSIONS The improved m-CPBA oxidative method is a convenient and efficient way to prepare the compound 6-benzyl-1-[(benzyloxy)methyl]-3-hydroxy-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione e which has both anti-HIV RT and IN activity.

UI MeSH Term Description Entries
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019428 HIV Integrase Inhibitors Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. Integrase Inhibitors, HIV,Inhibitors, HIV Integrase

Related Publications

Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
March 2008, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
July 2011, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
July 2014, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
February 2008, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
February 2014, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
July 2009, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
November 2014, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
September 2011, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
June 2010, Acta crystallographica. Section E, Structure reports online,
Xiao-wan Tang, and Liang Zhang, and Jian-xiong Zhao, and Yu Zhang, and Ying Guo, and Zhi-li Zhang, and Chao Tian, and Xiao-wei Wang, and Jun-yi Liu
August 2008, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!